tiprankstipranks
Charm Care Corporation (JP:6062)
:6062
Japanese Market

Charm Care Corporation (6062) AI Stock Analysis

Compare
1 Followers

Top Page

JP:6062

Charm Care Corporation

(6062)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥1,474.00
▲(16.06% Upside)
Action:UpgradedDate:11/12/25
Charm Care Corporation's stock is supported by strong technical indicators and a favorable valuation, suggesting potential upside. However, mixed financial performance, particularly declining revenue growth and negative free cash flow, pose risks. Investors should weigh these factors when considering the stock.
Positive Factors
Stable balance sheet and moderate leverage
A debt-to-equity of ~0.65 and a healthy equity ratio provide a durable capital base and room to raise or reallocate financing. Strong ROE indicates management extracts solid returns from equity, supporting resilience to shocks and preserving funding flexibility over the next several months.
Negative Factors
Declining revenue growth
A sustained decline in revenue growth undermines long-term earnings power and limits the ability to absorb rising costs. Slowing top-line reduces reinvestment capacity and increases pressure on margins and strategic initiatives, posing a structural headwind for recovery over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable balance sheet and moderate leverage
A debt-to-equity of ~0.65 and a healthy equity ratio provide a durable capital base and room to raise or reallocate financing. Strong ROE indicates management extracts solid returns from equity, supporting resilience to shocks and preserving funding flexibility over the next several months.
Read all positive factors

Charm Care Corporation (6062) vs. iShares MSCI Japan ETF (EWJ)

Charm Care Corporation Business Overview & Revenue Model

Company Description
Charm Care Corporation engages in nursing care business. It operates pay nursing homes with approximately 4,191 rooms in the Tokyo metropolitan and Kinki areas. The company was formerly known as Fuji Clinic Laboratory and changed its name to Charm...
How the Company Makes Money
null...

Charm Care Corporation Financial Statement Overview

Summary
Charm Care Corporation shows mixed financial performance. While operational efficiency and a stable balance sheet are positives, declining revenue growth and negative free cash flow are significant concerns. Addressing these issues is crucial for long-term sustainability.
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
50
Neutral
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue46.67B47.83B37.89B29.07B22.98B
Gross Profit7.24B8.31B6.84B4.65B3.95B
EBITDA5.69B6.31B5.78B5.38B2.85B
Net Income2.94B4.28B3.21B2.95B1.54B
Balance Sheet
Total Assets52.41B47.34B43.30B37.36B28.64B
Cash, Cash Equivalents and Short-Term Investments15.42B17.91B11.54B11.39B5.94B
Total Debt13.45B10.88B13.16B10.88B8.31B
Total Liabilities31.73B28.63B28.17B24.90B17.52B
Stockholders Equity20.68B18.71B15.13B12.46B11.13B
Cash Flow
Free Cash Flow-964.00M6.51B-1.62B1.34B124.00M
Operating Cash Flow3.73B10.53B496.00M3.95B2.56B
Investing Cash Flow-8.51B-1.67B-2.24B-2.86B-3.70B
Financing Cash Flow1.28B-3.04B1.62B-87.92M1.47B

Charm Care Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1270.00
Price Trends
50DMA
1349.02
Negative
100DMA
1294.65
Positive
200DMA
1229.78
Positive
Market Momentum
MACD
-17.41
Positive
RSI
47.49
Neutral
STOCH
38.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6062, the sentiment is Positive. The current price of 1270 is below the 20-day moving average (MA) of 1356.60, below the 50-day MA of 1349.02, and above the 200-day MA of 1229.78, indicating a neutral trend. The MACD of -17.41 indicates Positive momentum. The RSI at 47.49 is Neutral, neither overbought nor oversold. The STOCH value of 38.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6062.

Charm Care Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥2.99B27.022.56%-3.06%-38.56%
72
Outperform
¥43.24B11.612.63%0.30%-31.28%
62
Neutral
¥40.60B10.690.91%15.77%-50.57%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥5.79B23.204.07%6.08%38.00%
45
Neutral
¥6.23B33.861.41%18.03%-11.68%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6062
Charm Care Corporation
1,326.00
-9.42
-0.71%
JP:2373
Care Twentyone Corporation
430.00
32.98
8.31%
JP:2425
Care Service Co., Ltd.
788.00
-72.00
-8.37%
JP:7061
Japan Hospice Holdings Inc.
739.00
-809.68
-52.28%
JP:7071
Amvis Holdings.Inc.
413.00
-66.82
-13.93%

Charm Care Corporation Corporate Events

Charm Care to Absorb Wholly Owned Subsidiary in Streamlining Merger
Feb 24, 2026
Charm Care Corporation will merge its wholly owned subsidiary CM Care Co., Ltd. through an absorption-type merger effective July 1, 2026, dissolving CM Care and consolidating its operations into the parent. The move is designed to streamline overl...
Charm Care Outlines Q2 FY2026 Results and Strategic Outlook
Feb 10, 2026
Charm Care Corporation has released its financial results for the second quarter of the fiscal year ending June 30, 2026, outlining its recent performance. The disclosure is accompanied by updates on its medium-term management plan, current corpor...
Charm Care Launches First Interim Dividend, Adds 20th-Anniversary Payout
Feb 5, 2026
Charm Care Corporation has approved its first-ever interim dividend for the fiscal year ending June 2026, setting a payout of ¥20 per share as of the December 31, 2025 record date, funded from retained earnings. This interim dividend consists...
Charm Care Delivers Double-Digit Profit Growth and Raises Interim Dividend for FY2026 First Half
Feb 5, 2026
Charm Care Corporation reported strong consolidated results for the first half of the fiscal year ending June 30, 2026, with net sales rising 11.4% year on year to ¥22.33 billion and profit attributable to owners of parent climbing 29.5% to &...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025